All In MedTech

Device Trial Radar · NCT01824394

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

reMARQable nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Last checked: Nov 19, 2026Latest source record: Feb 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 481 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

481

Actual

Start

Apr 1, 2013

Primary completion

Nov 26, 2017

Study completion Nov 26, 2017

Sponsor

Lead sponsor
Biosense Webster, Inc.Public (JNJ)
Sponsor type
Industry
First posted
Apr 4, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate safety and effectiveness of nMARQ Catheter System \[nMARQ\] compared with THERMOCOOL® Navigational Family of catheters in treating subjects with drug-refractory symptomatic paroxysmal atrial fibrillation (PAF).

Conditions

  • Atrial Fibrillation

Interventions

  • nMARQ Navigation CathetersDevice

  • NaviStar ThermoCool CathetersDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Early Onset Primary Adverse EventsTime frame: 30 days post-procedure
  2. Incidence of Early Onset Primary Adverse Events for the Intent-to-Treat and As-Treated PopulationTime frame: 30 days post-procedure

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.